Reporting season is over, now what?

Reporting season is nearly done.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Reporting season is nearly finished and the dust is settling on another compelling set of inside looks into how the business world is doing.

Unless you only have your eye on a few key shares it can be very hard to get a clear picture of new investment ideas when the whole share market is reporting.

I mentioned to one of my colleagues that reporting season is like Christmas, except we spend most of our time opening presents instead of getting to play with what's inside. We move onto the next package as soon as we've finished opening the last one.

Once the pace has slowed down we can take the time to really look at how our holdings performed, not just the headline figures. Is the investment thesis still intact? Was the result so good that we could buy more if the value is right?

There were a few short-term disappointments in my portfolio like Challenger Ltd (ASX: CGF) and InvoCare Limited (ASX: IVC). However, I'm confident of their long-term success and I'll be looking to top up if they don't rise in price.

I had a few positive surprises like Altium Limited (ASX: ALU) – who would have thought it would go up by more than 20% on the day?

Foolish takeaway

Now that reporting season is done it's also a good time to look at our watchlist and consider shares that aren't in our portfolio. I haven't yet identified any individual shares that I'm going to add to my portfolio, but over the coming days and weeks I'll be having a good dig into some ideas.

Motley Fool contributor Tristan Harrison owns shares of Altium, Challenger Limited, and InvoCare Limited. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool Australia owns shares of Altium. The Motley Fool Australia has recommended InvoCare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

3 monster stocks to hold for the next 3 years

These 3 ASX shares operate in different industries and could be worth holding for long-term growth over the next 3…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »